Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000034412 | SCV000148993 | benign | not provided | 2018-03-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22703879, 21488257, 24599579, 27153395, 24345752, 24113346, 29367705) |
Ambry Genetics | RCV000115084 | SCV000172880 | benign | Hereditary cancer-predisposing syndrome | 2014-12-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000144564 | SCV000252584 | benign | Familial adenomatous polyposis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000239004 | SCV000297019 | benign | Familial multiple polyposis syndrome | 2015-11-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000300515 | SCV000452006 | likely benign | APC-Associated Polyposis Disorders | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000115084 | SCV000681606 | benign | Hereditary cancer-predisposing syndrome | 2016-03-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000034412 | SCV000694033 | benign | not provided | 2016-12-05 | criteria provided, single submitter | clinical testing | Variant summary: The APC c.3468_3470delAGA (p.Glu1157del) variant causes deletion of a Glutamic acid in a run of 4 repetitive Glutamic acids. This variant was found in 148/121852 control chromosomes (1 homozygote), predominantly observed in the African subpopulation at a frequency of 0.0130777 (133/10170). This frequency is about 183 times the estimated maximal expected allele frequency of a pathogenic APC variant (0.0000714), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. The variant of interest has been reported in patients with familial adenomatous polyposis including co-occurrences with other potentially pathogenic variants (Grandval_2014), supporting for the benign outcome. In addition, multiple clinical diagnostic laboratories/reputable databases have classified this variant as likely benign/benign. Taken together, this variant is classified as Benign. |
Eurofins Ntd Llc |
RCV000254628 | SCV000703676 | benign | not specified | 2016-11-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000254628 | SCV000805395 | benign | not specified | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000144564 | SCV000838107 | benign | Familial adenomatous polyposis 1 | 2018-07-02 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000034412 | SCV000885022 | benign | not provided | 2023-06-19 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000034412 | SCV000887523 | benign | not provided | 2022-10-21 | criteria provided, single submitter | clinical testing | |
St. |
RCV000144564 | SCV001775520 | benign | Familial adenomatous polyposis 1 | 2021-08-02 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000254628 | SCV002069700 | benign | not specified | 2020-08-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000115084 | SCV002533747 | benign | Hereditary cancer-predisposing syndrome | 2020-08-11 | criteria provided, single submitter | curation | |
Institute for Biomarker Research, |
RCV000115084 | SCV004014987 | benign | Hereditary cancer-predisposing syndrome | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000254628 | SCV004025054 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996162 | SCV004839815 | benign | Classic or attenuated familial adenomatous polyposis | 2024-02-05 | criteria provided, single submitter | clinical testing | actually g.112174759_112174761del, c.3468_3470del, p.E1157del was c.3460_3462del, p.1154_1154del |
Myriad Genetics, |
RCV000144564 | SCV004931015 | likely benign | Familial adenomatous polyposis 1 | 2024-03-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Biesecker Lab/Clinical Genomics Section, |
RCV000034412 | SCV000043122 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |
Pathway Genomics | RCV000144564 | SCV000189856 | likely benign | Familial adenomatous polyposis 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
True Health Diagnostics | RCV000115084 | SCV000693478 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-25 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000254628 | SCV001807977 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000034412 | SCV001924114 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000254628 | SCV001927045 | benign | not specified | no assertion criteria provided | clinical testing |